Safety & Clinical Performance Study of Catheter Ablation With the Centauri System for Patients With Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT04523545
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Galaxy Medical, Inc.
- Registry
-
NCT04523545
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Croatia
- Registry status
- Unknown status
Technical summary
Registry record NCT04523545. Allocation not applicable; no masking; primary purpose treatment. Start 2020-09-28 (actual); primary completion 2023-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety & Clinical Performance Study of Catheter Ablation With the Centauri System for Patients With Atrial Fibrillation
- Acronym
- ECLIPSE AF
- Condition
- Atrial Fibrillation
- Intervention (Device)
- cardiac ablation
- Lead sponsor
- Galaxy Medical, Inc.
Record details
- Record id
cardio:ct-nct04523545- Content hash
2e5c75852290cae529ebdbb2ed1bb349bfb756f959456a7835d3854e6134d9d4